An Observational Pilot Study Evaluating the Feasibility of Conducting Genome-Wide Association Studies Utilizing Subject Provided Information in Subjects With Locally Recurrent or Metastatic Breast Cancer, Metastatic Colorectal Cancer, Metastatic Non-Squamous Non-Small Cell Lung Cancer, Recurrent Glioblastoma, or Metastatic Renal Cell Cancer Treated With Avastin.

Trial Profile

An Observational Pilot Study Evaluating the Feasibility of Conducting Genome-Wide Association Studies Utilizing Subject Provided Information in Subjects With Locally Recurrent or Metastatic Breast Cancer, Metastatic Colorectal Cancer, Metastatic Non-Squamous Non-Small Cell Lung Cancer, Recurrent Glioblastoma, or Metastatic Renal Cell Cancer Treated With Avastin.

Completed
Phase of Trial: Phase IV

Latest Information Update: 12 May 2015

At a glance

  • Drugs Bevacizumab (Primary)
  • Indications Advanced breast cancer; Breast cancer; Colorectal cancer; Glioblastoma; Non-small cell lung cancer; Renal cell carcinoma
  • Focus Pharmacogenomic; Therapeutic Use
  • Acronyms InVite
  • Sponsors Genentech
  • Most Recent Events

    • 07 May 2015 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record.
    • 03 Dec 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 22 Jan 2013 Official title and inclusion criteria amended as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top